Novology Pigmentation Reduction Bi-Phasic Serum For Dry To Combination Skin
- Hyperpigmentation
- Lightens Skin
- Dark Spots
101% Original
Lowest Price
Free Shipping
Novology Pigmentation Reduction Bi-Phasic Serum For Dry To Combination Skin
- Hyperpigmentation
- Lightens Skin
- Dark Spots
Product Description
The Novology Pigmentation Reduction Bi-Phasic Serum For Dry To Combination Skin, powered by HNR-3 technology, combines Hexylresorcinol, Niacinamide, and Retinyl Propionate to visibly reduce hyperpigmentation, dark spots, and post-inflammatory hyperpigmentation (PIH). Clinically proven from week 4, the serum addresses three pigmentation pathways for comprehensive results. Hypoallergenic and non-comedogenic, it offers effective and gentle care.
Key Benefits
- Reduce hyperpigmentation.
- Visibly diminishes dark spots.
- Treats Post-Inflammatory Hyperpigmentation (PIH).
- Hypoallergenic and non-comedogenic for gentle and effective skincare.
How to Use
- Shake it well before use till the colour changes to peach.
- Use twice daily.
- Apply at night for best results.
Key Ingredients
- Niacinamide
- Hexylresorcinol
- Retinyl Propionate
- Isodecyl Neopentanoate
- Glycerin
- Phenoxyethanol
- Sodium Chloride
- Cocamide MEA
- Linalool
- Tocopheryl Acetate
- Helianthus Annuus Seed Oil
Other Information
Country of Origin
India
Mfg/Marketer details
L.B.C.P., UNIT II, HARIDWAR 249 403, UTTARAKHAND. M 16/C/UA/2010.
COD Available
Pan-India
Free Delivery
Above ₹599
100% Real
Products
Dermatologist
Written
Frequently Asked Questions
The Novology Pigmentation Reduction Bi-Phasic Serum contains potent active ingredients, including Hexylresorcinol, Niacinamide, and Retinyl Propionate.
Clinical results indicate a reduction in hyperpigmentation starting from the fourth week of consistent use.
HNR-3 technology addresses three pigmentation pathways, providing a comprehensive approach to reducing hyperpigmentation.
Clinical proof demonstrates the Novology Pigmentation Reduction Bi-Phasic Serum efficacy in reducing hyperpigmentation through in vitro and human trials.
Yes, the Novology Pigmentation Reduction Bi-Phasic Serum is hypoallergenic and designed to be gentle on the skin, suitable for all skin types.
Hexylresorcinol is an effective tyrosinase inhibitor, proven to reduce melanin production and improve hyperpigmentation.
Yes, the Novology Pigmentation Reduction Bi-Phasic Serum is formulated to visibly reduce post-inflammatory hyperpigmentation (PIH) along with dark spots.
For best results, use the Novology Pigmentation Reduction Bi-Phasic Serum consistently as part of your daily skincare routine.
The Novology Pigmentation Reduction Bi-Phasic Serum contains potent active ingredients, including Hexylresorcinol, Niacinamide, and Retinyl Propionate.
Clinical results indicate a reduction in hyperpigmentation starting from the fourth week of consistent use.
HNR-3 technology addresses three pigmentation pathways, providing a comprehensive approach to reducing hyperpigmentation.
Clinical proof demonstrates the Novology Pigmentation Reduction Bi-Phasic Serum efficacy in reducing hyperpigmentation through in vitro and human trials.
Yes, the Novology Pigmentation Reduction Bi-Phasic Serum is hypoallergenic and designed to be gentle on the skin, suitable for all skin types.
Hexylresorcinol is an effective tyrosinase inhibitor, proven to reduce melanin production and improve hyperpigmentation.
Yes, the Novology Pigmentation Reduction Bi-Phasic Serum is formulated to visibly reduce post-inflammatory hyperpigmentation (PIH) along with dark spots.
For best results, use the Novology Pigmentation Reduction Bi-Phasic Serum consistently as part of your daily skincare routine.
Featured In
